Association of Social Gaming with Well-Being (Escape COVID-19): A Sentiment Analysis - 08/02/22


ABSTRACT |
Background |
During the 2020-2021 coronavirus disease 2019 (COVID-19) lockdown, social activities were limited by the government-recommended social distancing guidelines, leading to an abundance of mental health issues.
Methods |
We hypothesized that Twitter sentiment analysis may shed some light on Animal Crossing: New Horizons and its impact on mental health during the COVID-19 pandemic.
Results |
We found that social gaming and social media may be used as tools to cope with stress during the COVID-19 pandemic.
Conclusions |
Further research, including randomized study designs and prospective measurements of mental health outcomes related to social gaming behavior are required.
El texto completo de este artículo está disponible en PDF.Keywords : Sentiment analysis, Social gaming, Twitter, Well-Being
Esquema
Funding: None. |
|
Conflicts of Interest: HUHV, SK, ZW, CLJ report none. CK reports being a Member of the American College of Cardiology Solution Set Oversight Committee, the American Heart Association Committee of the Council on Genomic and Precision Medicine, and the American College of Cardiology/American Heart Association Task Force on Performance Measures, The Lancet Digital Health (Advisory Board), European Heart Journal Digital Health (Editorial board), Journal of the American Heart Association (Editorial Board), Journal of the American College of Cardiology: Asia (Section Editor), and The Journal of Scientific Innovation in Medicine (Associate Editor), and Frontiers in Cardiovascular Medicine (Associate Editor). CLK reports serving as Consultant, Advanced Recovery Systems and RANE Crisis Network. Dr. Gonzalez-Heydrich discloses the following relationships: JG-H reports having founded and equity in Neuromotion Labs, a company that creates emotional regulation training technologies, outside the submitted work; a pending patent US20140323013A1: Emotional control methods and apparatus licensed; and a patent European Patent 99112065.0-2201. Aug 17, 1999 US Patent 6,211,876. April 3, 2001 pending. EAS reports serving as a consultant for Biohaven Pharmaceuticals; Book royalties from Elsevier, Springer, American Psychological Association, Wiley, Oxford, Kingsley, and Guilford; Research support from NIH, IOCDF, Ream Foundation, and Texas Higher Education Coordinating Board. |
|
Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 135 - N° 2
P. 254-257 - février 2022 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.